## CBOE: Cboe Global Markets, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -1.1% below STRENGTH zone (4.0-10.0%); PEG 2.09 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($244.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. How Investors Are Reacting To Cboe Global Markets (CBOE) Barclays Upgrade And 24-Hour Russell 2000 Options**
- Source: Simply Wall Street | 20251214T150759 | Somewhat-Bullish | Relevance: 100%
- Barclays recently upgraded Cboe Global Markets to Overweight, citing strong growth in index options and retail options activity, alongside a focus on core derivatives. Cboe also plans to extend Russell 2000 Index options to nearly 24-hour trading by February 2026, enhancing access to its proprietary index products. These developments reinforce Cboe's growth narrative, although investors should consider its concentration risk in core index franchises and potential fee pressures.

**2. This CBOE Pullback Could Be a Big Win**
- Source: Finviz | 20251212T155400 | Bullish | Relevance: 100%
- Cboe Global Markets (CBOE) stock has pulled back from its November peak to its 30-day moving average and the $250 support level, despite outperforming the S&P 500 Index in 2025. This presents a potential buying opportunity, especially considering that analysts are largely skeptical and short interest remains high, suggesting a possible round of bullish analyst upgrades and short covering. Implied volatility is also at a one-year low.

**3. Cboe Global Markets Stock: Is CBOE Outperforming the Financial Sector?**
- Source: inkl | 20251211T150808 | Bullish | Relevance: 100%
- Cboe Global Markets (CBOE) has demonstrated strong outperformance compared to the broader financial sector, with significant gains over the past three months, 52 weeks, and year-to-date. The company's recent Q3 earnings report highlighted record revenues and adjusted EPS, however, analysts remain cautious with a "Hold" rating despite the positive financial results and market trajectory.

**4. Cboe Global Markets Announces Date of Fourth-Quarter 2025 Earnings Release and Conference Call**
- Source: The AI Journal | 20251210T215129 | Neutral | Relevance: 100%
- Cboe Global Markets, Inc. (CBOE) will release its fourth-quarter 2025 financial results on Friday, February 6, 2026, before the market opens. A conference call with senior management will follow at 7:30 a.m. CT (8:30 a.m. ET), with a live audio webcast and presentation available on the Investor Relations section of Cboeâ€™s website. The company is a leading derivatives and securities exchange network providing various trading solutions globally.

**5. Cboe Global Markets Announces Date of Fourth-Quarter 2025 Earnings Release and Conference Call**
- Source: StreetInsider | 20251210T211017 | Neutral | Relevance: 100%
- Cboe Global Markets, Inc. announced that it will release its fourth-quarter 2025 financial results on Friday, February 6, 2026, before the market opens. A conference call with senior management will follow at 7:30 a.m. CT (8:30 a.m. ET) and a live audio webcast will be available on the company's Investor Relations website. The presentation and a replay of the call will also be archived on the website.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $302 | $273 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+0.0%)
- Blackrock Inc.: 9.0% (-2.7%)
- Alliancebernstein L.: 6.1% (-31.2%)
- State Street Corpora: 4.5% (+2.1%)
- FMR, LLC: 4.3% (+62.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.09 elevated, pricing in significant growth expectations. Forward P/E 23.3x stretched relative to 5% growth. Quality metrics strong (ROE 22%, margin 21%). Analyst sentiment positive (1 raises, avg +11%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.5B |
| Beta | 0.35 |
| 52W Range | $187.30 - $262.98 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.09 |
| Forward P/E | 23.3 |
| Current P/E | 24.4 |
| YoY Growth | 4.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -3.3% to -1.1% (+2.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 5.1pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.8%) - potential reversal signal. Underperforming sector by 4.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). MACD histogram bearish (-1.01), momentum weakening. RSI neutral at 51. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.11% (CS: 29) | Neutral |
| RSI_14 | 51.1 | Neutral |
| MACD Histogram | -1.01 | Bearish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 1.081x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $253.02
- **Stop Loss:** $244.00 (3.6% risk)
- **Target:** $262.04 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 133
- **Position Value:** $33,651.66
- **Portfolio %:** 33.65%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-06 (Est: $2.73)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.53 | $2.67 | +5.6% |
| 2025Q2 | $2.44 | $2.46 | +0.6% |
| 2025Q1 | $2.36 | $2.50 | +5.8% |
| 2024Q4 | $2.12 | $2.10 | -0.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*